ePharma

Doctors seek more transparency from drugmakers: ePharma panel

Doctors seek more transparency from drugmakers: ePharma panel

By

Pharmaceutical companies often blur the lines between a drug's risks and benefits in ads, and that frustrates physicians.

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

By

Technology executives discussed how pharma companies can leverage social media to better engage with patients online.